Centers for Medicare & Medicaid Services

Content Section

10 : Anesthesia and Pain Management

10.1 : Use of Visual Tests Prior to and General Anesthesia during Cataract Surgery

10.2 : Transcutaneous Electrical Nerve Stimulation (TENS) for Acute Post-Operative Pain

10.3 : Inpatient Hospital Pain Rehabilitation Programs

10.4 : Outpatient Hospital Pain Rehabilitation Programs

10.5 : Autogenous Epidural Blood Graft

20 : Cardiovascular System

20.1 : Vertebral Artery Surgery

20.2 : Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery

20.3 : Thoracic Duct Drainage (TDD) in Renal Transplants

20.4 : Implantable Automatic Defibrillators

20.5 : Extracorporeal Immunoadsorption (ECI) Using Protein A Columns

20.6 : Transmyocardial Revascularization (TMR)

20.7 : Percutaneous Transluminal Angioplasty (PTA)

20.8 : Cardiac Pacemakers

20.8.1 : Cardiac Pacemaker Evaluation Services

20.8.2 : Self-Contained Pacemaker Monitors

20.8.3 : Anesthesia in Cardiac Pacemaker Surgery

20.9 : Artificial Hearts and Related Devices

20.10 : Cardiac Rehabilitation Programs

20.11 : Intraoperative Ventricular Mapping

20.12 : Diagnostic Endocardial Electrical Stimulation (Pacing)

20.13 : HIS Bundle Study

20.14 : Plethysmography

20.15 : Electrocardiographic (EKG) Services

20.16 : Cardiac Output Monitoring by Thoracic Electrical Bioimpedance (TEB)

20.17 : Noninvasive Tests of Carotid Function

20.18 : Carotid Body Resection/Carotid Body Denervation

20.19 : Ambulatory Blood Pressure Monitoring

20.20 : External Counterpulsation (ECP) for Severe Angina

20.21 : Chelation Therapy for Treatment of Atherosclerosis

20.22 : Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of Atherosclerosis

20.23 : Fabric Wrapping of Abdominal Aneurysms

20.24 : Displacement Cardiography

20.25 : Cardiac Catheterization Performed in Other than a Hospital Setting

20.26 : Partial Ventriculectomy

20.27 : Cardiointegram (CIG) as an Alternative to Stress Test or Thallium Stress Test

20.28 : Therapeutic Embolization

20.29 : Hyperbaric Oxygen Therapy

20.30 : Microvolt T-Wave Alternans(MTWA)

30 : Complementary and Alternative Medicine

30.1 : Biofeedback Therapy

30.1.1 : Biofeedback Therapy for the Treatment of Urinary Incontinence

30.2 : Thermogenic Therapy

30.3 : Acupuncture

30.3.1 : Acupuncture for Fibromyalgia

30.3.2 : Acupuncture for Osteoarthritis

30.4 : Electrosleep Therapy

30.5 : Transcendental Meditation (TM)

30.6 : Intravenous Histamine Therapy

30.7 : Laetrile and Related Substances

30.8 : Cellular Therapy

30.9 : Transillumination Light Scanning or Diaphanography

40 : Endocrine System and Metabolism

40.1 : Diabetes Outpatient Self-Management Training

40.2 : Home Blood Glucose Monitors

40.3 : Closed-Loop Blood Glucose Control Device (CBGCD)

40.4 : Insulin Syringe

40.5 : Treatment of Obesity

50 : Ear, Nose and Throat (ENT)

50.1 : Speech Generating Devices

50.2 : Electronic Speech Aids

50.3 : Cochlear Implantation

50.4 : Tracheostomy Speaking Valve

50.5 : Oxygen Treatment of Inner Ear/Carbon Therapy

50.6 : Tinnitus Masking

50.7 : Cochleostomy with Neurovascular Transplant for Meniere's Disease

50.8 : Ultrasonic Surgery

60 : Emergency Medicine

70 : Evaluation and Management of Patients - Office/hospital/home

70.1 : Consultations with a Beneficiary's Family and Associates

70.2 : Consultation Services Rendered by a Podiatrist in a Skilled Nursing Facility

70.2.1 : Services Provided for the Diagnosis and Treatment of Diabetic Sensory Neuropathy with Loss of Protective Sensation (aka Diabetic Peripheral Neuropathy)

70.3 : Physician's Office Within an Institution--Coverage of Services and Supplies Incident to a Physician's Services

70.4 : Pronouncement of Death

70.5 : Hospital and Skilled Nursing Facility Admission Diagnostic Procedures

80 : Eye

80.1 : Hydrophilic Contact Lens For Corneal Bandage

80.2 : Ocular Photodynamic Therapy (OPT)

80.3 : Verteporfin

80.4 : Hydrophilic Contact Lenses

80.5 : Scleral Shell

80.6 : Intraocular Photography

80.7 : Refractive Keratoplasty

80.8 : Endothelial Cell Photography

80.9 : Computer Enhanced Perimetry

80.10 : Phaco-Emulsification Procedure - Cataract Extraction

80.11 : Vitrectomy

80.12 : Intraocular Lenses (IOLs)

90 : Genetics

100 : Gastrointestinal System

100.1 : Bariatric Surgery for Treatment of Morbid Obesity

100.2 : Endoscopy

100.3 : 24-Hour Ambulatory Esophageal pH Monitoring

100.4 : Esophageal Manometry

100.5 : Diagnostic Breath Analyses

100.6 : Gastric Freezing

100.7 : Colonic Irrigation

100.8 : Intestinal Bypass Surgery

100.9 : Implantation of Anti-Gastroesophageal Reflux Device

100.10 : Injection Sclerotherapy for Esophageal Variceal Bleeding

100.11 : Gastric Balloon for Treatment of Obesity

100.12 : Gastrophotography

100.13 : Laparoscopic Cholecystectomy

110 : Hematology/Immunology/Oncology

110.1 : Hyperthermia for Treatment of Cancer

110.2 : Certain Drugs Distributed by the National Cancer Institute

110.3 : Anti-Inhibitor Coagulant Complex (AICC)

110.4 : Extracorporeal Photopheresis

110.5 : Granulocyte Transfusions

110.6 : Scalp Hypothermia During Chemotherapy to Prevent Hair Loss

110.7 : Blood Transfusions

110.8 : Blood Platelet Transfusions

110.8.1 : Stem Cell Transplantation

110.9 : Antigens Prepared for Sublingual Administration

110.10 : Intravenous Iron Therapy

110.11 : Food Allergy Testing and Treatment

110.12 : Challenge Ingestion Food Testing

110.13 : Cytotoxic Food Tests

110.14 : Apheresis (Therapeutic Pheresis)

110.15 : Ultrafiltration, Hemoperfusion and Hemofiltration

110.16 : Nonselective (Random) Transfusions and Living Related Donor Specific Transfusions (DST) in Kidney Transplantation

110.17 : Anti-Cancer Chemotherapy for Colorectal Cancer

110.18 : Aprepitant for Chemotherapy-Induced Emesis

110.19 : Abarelix for the Treatment of Prostate Cancer

110.20 : Blood Brain Barrier Osmotic Disruption for Treatment of Brain Tumors(Effective March 20, 2007)

110.21 : Erythropoiesis Stimulating Agents(ESAs) in Cancer and Related Neoplastic Conditions

120 : Infectious Diseases

130 : Mental Health

130.1 : Inpatient Hospital Stays for Treatment of Alcoholism

130.2 : Outpatient Hospital Services for Treatment of Alcoholism

130.3 : Chemical AversionTherapy for Treatment of Alcoholism

130.4 : Electrical Aversion Therapy for Treatment of Alcoholism

130.5 : Treatment of Alcoholism and Drug Abuse in a Freestanding Clinic

130.6 : Treatment of Drug Abuse (Chemical Dependency)

130.7 : Withdrawal Treatments for Narcotic Addictions

130.8 : Hemodialysis for Treatment of Schizophrenia

140 : Miscellaneous Surgical Procedures

140.1 : Abortion

140.2 : Breast Reconstruction Following Mastectomy

140.3 : Transsexual Surgery

140.4 : Plastic Surgery to Correct Moon Face

140.5 : Laser Procedures

150 : Musculoskeletal System

150.1 : Manipulation

150.2 : Osteogenic Stimulators

150.3 : Bone (Mineral) Density Studies

150.5 : Diathermy Treatment

150.6 : Vitamin B12 Injections to Strengthen Tendons, Ligaments, etc., of the Foot

150.7 : Prolotherapy, Joint Sclerotherapy, and Ligamentous Injections with Sclerosing Agents

150.8 : Fluidized Therapy Dry Heat for Certain Musculoskeletal Disorders

150.9 : Arthroscopic Lavage and Arthroscopic Debridement for the Osteoarthritic Knee

150.10 : Lumbar Artificial Disc Replacement(LADR)

160 : Nervous System

160.1 : Induced Lesions of Nerve Tracts

160.2 : Treatment of Motor Function Disorders with Electric Nerve Stimulation

160.4 : Stereotactic Cingulotomy as a Means of Psychosurgery

160.5 : Stereotaxic Depth Electrode Implantation

160.6 : Carotid Sinus Nerve Stimulator

160.7 : Electrical Nerve Stimulators

160.7.1 : Assessing Patient's Suitability for Electrical Nerve Stimulation Therapy

160.8 : Electroencephalographic (EEG) Monitoring During Surgical Procedures Involving the Cerebral Vasculature

160.9 : Electronecephalographic (EEG) Monitoring During Open-Heart Surgery

160.10 : Evoked Response Tests

160.12 : Neuromuscular Electrical Stimulaton (NMES)

160.13 : Supplies Used in the Delivery of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES)

160.14 : Invasive Intracranial Pressure Monitoring

160.15 : Electrotherapy for Treatment of Facial Nerve Paralysis (Bell's Palsy)

160.16 : Vertebral Axial Decompression (VAX-D)

160.17 : L-Dopa

160.18 : Vagus Nerve Stimulation for Treatment of Seizures

160.19 : Phrenic Nerve Stimulator

160.20 : Transfer Factor for Treatment of Multiple Sclerosis

160.21 : Telephone Transmission of Electroencephalograms (EEGs)

160.22 : Ambulatory EEG Monitoring

160.23 : Sensory Nerve Conduction Threshold Tests (sNCTs)

160.24 : Deep Brain Stimulation for Essential Tremor and Parkinson’s Disease

160.25 : Multiple Electroconvulsive Therapy (MECT)

160.26 : Cavernous Nerves by Electrical Stimulation with Penile Plethsmography

170 : Nonphysician Practitioner Services (PT/OT/SLP/Audiologists/CRNA

170.1 : Institutional and Home Care Patient Education Programs

170.2 : Melodic Intonation Therapy

170.3 : Speech-Language Pathology Services for the Treatment of Dysphagia

180 : Nutrition

180.1 : Medical Nutrition Therapy

180.2 : Enteral and Parenteral Nutritional Therapy

190 : Pathology and Laboratory

190.1 : Histocompatibility Testing

190.2 : Diagnostic Pap Smears

190.3 : Cytogenetic Studies

190.4 : Electron Microscope

190.5 : Sweat Test

190.6 : Hair Analysis

190.7 : Human Tumor Stem Cell Drug Sensitivity Assays

190.8 : Lymphocyte Mitogen Response Assays

190.9 : Serologic Testing for Acquired Immunodeficiency Syndrome (AIDS)

190.10 : Laboratory Tests - CRD Patients

190.11 : Home Prothrombin Time INR Monitoring for Anticoagulation Management

190.12 : Urine Culture, Bacterial

190.13 : Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring)

190.14 : Human Immunodeficiency Virus (HIV) Testing (Diagnosis)

190.15 : Blood Counts

190.16 : Partial ThromboplastinTime (PTT)

190.17 : Prothrombin Time (PT)

190.18 : Serum Iron Studies

190.19 : Collagen Crosslinks, any Method

190.20 : Blood Glucose Testing

190.21 : Glycated Hemoglobin/Glycated Protein

190.22 : Thyroid Testing

190.23 : Lipid Testing

190.24 : Digoxin Therapeutic Drug Assay

190.25 : Alpha-fetoprotein (AFP)

190.26 : Carcinoembryonic Antigen (CEA)

190.27 : Human Chorionic Gonadotropin (hCG)

190.28 : Tumor Antigen by Immunoassay - CA 125

190.29 : Tumor Antigen by Immunoassay - CA 15-3/CA 27.29

190.30 : Tumor Antigen by Immunoassay - CA 19-9

190.31 : Prostate Specific Antigen (PSA)

190.32 : Gamma Glutamyl Transferase (GGT)

190.33 : Hepatitis Panel/Acute Hepatitis Panel

190.34 : Fecal Occult Blood Test (FOBT)

200 : Pharmacology

200.1 : Nesiritide for Treatment of Heart Failure Patients

200.2 : Nebulized Beta Adrenergic Agonist Therapy for Lung Diseases

210 : Prevention

210.1 : Prostate Cancer Screening Tests

210.2 : Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer

210.3 : Colorectal Cancer Screening Tests

210.4 : Smoking and Tobacco-Use Cessation Counseling

220 : Radiology

220.1 : Computed Tomography

220.2 : Magnetic Resonance Imaging (MRI)

220.2.1 : Magnetic Resonance Spectroscopy (MRS)

220.3 : Magnetic Resonance Angiography (MRA)

220.4 : Mammograms

220.5 : Ultrasound Diagnostic Procedures

220.6 : PET Scans

220.6.10 : PET (FDG) for Breast Cancer

220.6.1 : PET for Perfusion of the Heart

220.6.11 : PET (FDG) for Thyroid Cancer

220.6.12 : PET (FDG) for Soft Tissue Sarcoma

220.6.13 : PET (FDG) for Dementia and Neurodegenerative Diseases

220.6.14 : PET (FDG) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers

220.6.15 : PET (FDG) for All Other Cancer Indications Not Previously Specified

220.6.16 : PET for Infection and Inflammation

220.6.2 : PET (FDG) for Lung Cancer

220.6.3 : PET (FDG) for Esophageal Cancer

220.6.4 : PET (FDG) for Colorectal Cancer

220.6.5 : PET (FDG) for Lymphoma

220.6.6 : PET (FDG) for Melanoma

220.6.7 : PET (FDG) for Head and Neck Cancers

220.6.8 : PET (FDG) for Myocardial Viability

220.6.9 : PET (FDG) for Refractory Seizures

220.7 : Xenon Scan

220.8 : Nuclear Radiology Procedure

220.9 : Digital Subtraction Angiography

220.10 : Portable Hand-Held X-Ray Instrument

220.11 : Thermography

220.12 : Single Photon Emission Computed Tomography (SPECT)

220.13 : Percutaneous Image-Guided Breast Biopsy

230 : Renal and Genitourinary System - ESRD Services

230.1 : Treatment of Kidney Stones

230.2 : Uroflowmetric Evaluations

230.3 : Sterilization

230.4 : Diagnosis and Treatment of Impotence

230.5 : Gravlee Jet Washer

230.6 : Vabra Aspirator

230.7 : Water Purification and Softening Systems Used in Conjunction with Home Dialysis

230.8 : Non-Implantable Pelvic Floor Electrical Stimulator

230.9 : Cryosurgery of Prostate

230.10 : Incontinence Control Devices

230.12 : Dimethyl Sulfoxide (DMSO)

230.13 : Peridex CAPD Filter Set

230.14 : Ultrafiltration Monitor

230.15 : Electrical Continence Aid

230.16 : Bladder Stimulators (Pacemakers)

230.17 : Urinary Drainage Bags

230.18 : Sacral Nerve Stimulation For Urinary Incontinence

230.19 : Levocarnitine for use in the Treatment of Carnitine Deficiency in ESRD Patients

240 : Respiratory System

240.1 : Lung Volume Reduction Surgery (Reduction Pneumoplasty)

240.2 : Home Use of Oxygen

240.2.1 : Home Use of Oxygen in Approved Clinical Trials

240.3 : Heat Treatment, including the Use of Diathermy and Ultrasound for Pulmonary Conditions

240.4 : Continuous Positive Airway Pressure (CPAP) Therapy For Obstructive Sleep Apnea (OSA)

240.5 : Intrapulmonary Percussive Ventilator (IPV)

240.6 : Transvenous (Catheter) Pulmonary Embolectomy

240.7 : Postural Drainage Procedures and Pulmonary Exercises

240.8 : Pulmonary Rehabilitation Services

250 : Skin

250.1 : Treatment of Psoriasis

250.2 : Hemorheograph

250.3 : Intravenous Immune Globulin for the Treatment of Autoimmune Mucocutaneous Blistering Diseases

250.4 : Treatment of Actinic Keratosis (AKs)

260 : Transplantation - Solid Organ Transplants

260.1 : Adult Liver Transplantation

260.2 : Pediatric Liver Transplantation

260.3 : Pancreas Transplants

260.3.1 : Islet Cell Transplantation in the Context of a Clinical Trial

260.5 : Intestinal and Multi-Visceral Transplantation

260.6 : Dental Examination Prior to Kidney Transplantation

260.7 : Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine)

260.9 : Heart Transplants

270 : Wound Treatment

270.1 : Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of Wounds

270.2 : Noncontact Normothermic Wound Therapy (NNWT)

270.3 : Blood-Derived Products for Chronic Non-Healing Wounds

270.4 : Treatment of Decubitus Ulcers

270.5 : Porcine Skin and Gradient Pressure Dressings

270.6 : Infrared Therapy Devices

280 : Medical and Surgical Supplies

280.1 : Durable Medical Equipment Reference List

280.2 : White Cane for Use by a Blind Person

280.3 : Mobility Assistive Equipment (MAE)

280.4 : Seat Lift

280.5 : Safety Roller

280.6 : Pneumatic Compression Devices

280.7 : Hospital Beds

280.8 : Air-Fluidized Bed

280.10 : Prosthetic Shoe

280.11 : Corset Used as Hernia Support

280.12 : Sykes Hernia Control

280.13 : Transcutaneous Electrical Nerve Stimulators (TENS)

280.14 : Infusion Pumps

280.15 : INDEPENDENCE iBOT 4000 Mobility System

290 : Nursing Services

290.1 : Home Health Visits to a Blind Diabetic

290.2 : Home Health Nurses' Visits to Patients Requiring Heparin Injection

300 : Diagnostic Tests Not Otherwise Classified

300.1 : Obsolete or Unreliable Diagnostic Tests

310 : Clinical Trials

310.1 : Routine Costs in Clinical Trials

Page Last Modified: 5/30/2008 4:06:34 PM

Help with File Formats and Plug-Ins

Submit Feedback

Medicare Coverage Database

NCD Chapters